BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...
Medical Device Network on MSN
BD and Ypsomed develop new version of Neopak XtraFlow syringe
The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.
Add Yahoo as a preferred source to see more of our stories on Google. Bioengineers in South Korea have succeeded in developing an intravenous needle (IV) that can bend and flex as it enters the human ...
Objective—We aimed to establish the ideal injection techniques using 5-mm needles to reliably inject insulin into the subcutaneous fat in both children and adults and to quantify the associated pain ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...
This study demonstrated that 32-G 5-mm needles can be reliably inserted into subcutaneous fat, are relatively pain free, and are associated with minimal leakage from the injection site. Previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results